Alterity Therapeutics (ATHE) Cash & Equivalents Growth (5y) (2014 - 2025)

Alterity Therapeutics (ATHE) Cash & Equivalents Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.75%
Jun 30, 2025 28.64%
Dec 31, 2024 -18.64%
Jun 30, 2024 -3.76%
Dec 31, 2023 5.93%
Jun 30, 2023 -1.78%
Dec 31, 2022 1.69%
Jun 30, 2022 8.68%
Dec 31, 2021 4.86%
Jun 30, 2021 0.28%
Dec 31, 2020 0.39%
Jun 30, 2020 -25.99%
Dec 31, 2019 -24.61%
Jun 30, 2017 23.61%
Dec 31, 2016 18.93%
Jun 30, 2016 17.87%
Dec 31, 2015 54.20%
Jun 30, 2015 42.49%
Dec 31, 2014 32.48%